Development of zika viral pseudoinfectious virus as zika vaccine candidate
Ended Project Grant Awarded Last action
- Award ID
- R41AI129119
- Recipient
-
Tengen Biomedical Co UEI SKN6JEPE9Z76
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $456,000
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding
-
- $404,000.00 Federal
- $52,000.00 Non-federal
- Place of performance
- Washington, DC 20059, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $52,000 | $0 | |
| Amendment | $52,000 | $52,000 | |
| Amendment | $0 | $0 | |
| Original award | $300,000 | $0 |
Quick answers
Who received award R41AI129119?
R41AI129119 was awarded to Tengen Biomedical Co by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2017.
How much is award R41AI129119 worth?
$456,000 has been obligated on R41AI129119: $404,000 in federal funding and $52,000 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award